Screening for COVID-19 in Asymptomatic Patients Receiving Anticancer Therapy | Cancer Screening, Prevention, Control | JN Learning | AMA Ed Hub [Skip to Content]
[Skip to Content Landing]

Serial Screening for COVID-19 in Asymptomatic Patients Receiving Anticancer Therapy in the United Arab Emirates

Educational Objective
To identify the key insights or developments described in this article
1 Credit CME

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.

Article Information

Accepted for Publication: September 1, 2020.

Published Online: November 5, 2020. doi:10.1001/jamaoncol.2020.5745

Corresponding Author: Humaid O. Al-Shamsi, MD, Burjeel Oncology-Burjeel Medical City, 28th Street, Mohammad Bin Zayed City, Abu Dhabi, United Arab Emirates, PO box 9054 (humaid.al-shamsi@medportal.ca).

Open Access: This is an open access article distributed under the terms of the CC-BY-NC-ND License. © 2020 Al-Shamsi HO et al. JAMA Oncology.

Author Contributions: Drs Al-Shamsi and Alrawi had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Drs Al-Shamsi and Coomes were co-first authors.

Concept and design: Al-Shamsi, Coomes.

Acquisition, analysis, or interpretation of data: All authors.

Drafting of the manuscript: Al-Shamsi, Coomes, Alrawi.

Critical revision of the manuscript for important intellectual content: Al-Shamsi, Coomes, Aldhaheri.

Statistical analysis: Al-Shamsi, Coomes.

Obtained funding: Al-Shamsi.

Administrative, technical, or material support: Al-Shamsi.

Supervision: Al-Shamsi, Alrawi.

Conflict of Interest Disclosures: Dr Al-Shamsi received publication funding from Roche Pharmaceuticals Middle East Free Zone Company. Dr Coomes reports grants from Toronto COVID-19 Action Fund, Thistledown Foundation, and the British Society of Antimicrobial Chemotherapy outside the submitted work. No other conflicts are reported.

Funding/Support: Roche Pharmaceuticals Middle East Free Zone Company, Dubai, United Arab Emirates.

Role of the Funder/Sponsor: Roche Pharmaceuticals had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Roche Pharmaceuticals provided funding for open-access publication.

Additional Contributions: We thank all patients and their families who were enrolled in this study.

References
1.
Al-Shamsi  HO , Alhazzani  W , Alhuraiji  A ,  et al.  A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID-19) pandemic: an international collaborative group.   Oncologist. 2020;25(6):e936-e945. doi:10.1634/theoncologist.2020-0213PubMedGoogle ScholarCrossref
2.
Al-Shamsi  HO , Coomes  EA , Alrawi  S .  Screening for COVID-19 in asymptomatic patients with cancer in a hospital in the united arab emirates.   JAMA Oncol. 2020. doi:10.1001/jamaoncol.2020.2548PubMedGoogle Scholar
3.
Zhang  L , Zhu  F , Xie  L ,  et al.  Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China.   Ann Oncol. 2020;31(7):894-901. doi:10.1016/j.annonc.2020.03.296PubMedGoogle ScholarCrossref
4.
Treibel  TA , Manisty  C , Burton  M ,  et al.  COVID-19: PCR screening of asymptomatic health-care workers at London hospital.   Lancet. 2020;395(10237):1608-1610. doi:10.1016/S0140-6736(20)31100-4PubMedGoogle ScholarCrossref
5.
Arons  MM , Hatfield  KM , Reddy  SC ,  et al; Public Health–Seattle and King County and CDC COVID-19 Investigation Team.  Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility.   N Engl J Med. 2020;382(22):2081-2090. doi:10.1056/NEJMoa2008457PubMedGoogle ScholarCrossref
6.
Al-Muharraqi  MA .  Testing recommendation for COVID-19 (SARS-CoV-2) in patients planned for surgery: continuing the service and 'suppressing' the pandemic.   Br J Oral Maxillofac Surg. 2020;58(5):503-505. doi:10.1016/j.bjoms.2020.04.014Google ScholarCrossref
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_Multimedia_LoginSubscribe_Purchase
Close
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_Multimedia_LoginSubscribe_Purchase
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
Close
With a personal account, you can:
  • Track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
jn-learning_Modal_SaveSearch_NoAccess_Purchase
Close

Lookup An Activity

or

Close

My Saved Searches

You currently have no searches saved.

Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close